Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
about
The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerUp-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissueLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerDeletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell RecruitmentExpression of 5-lipoxygenase in pulmonary artery endothelial cellsMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisDiscovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse librariesLncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method.Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapiesDiscovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.The role of cyclooxygenase and lipoxygenase in cancer chemoprevention.Fatty acid oxidation and signaling in apoptosis.Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.Identification and Characterization of a New Protein Isoform of Human 5-LipoxygenaseLipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer PreventionMechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cellsCancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.Ablation of 5-lipoxygenase mitigates pancreatic lesion developmentRole of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer.Baicalein--an intriguing therapeutic phytochemical in pancreatic cancer.Convergence of eicosanoid and integrin biology: Role of Src in 12-LOX activation.3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.Potent inhibitors of 5-lipoxygenase identified using pseudoreceptors.5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity.Anti-apoptotic effects of arachidonic acid and prostaglandin E2 in pancreatic beta-cells.Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase.5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis.Analysis of a nucleotide-binding site of 5-lipoxygenase by affinity labelling: binding characteristics and amino acid sequences.Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.5-Lipoxygenase and human pulmonary artery endothelial cell proliferation.Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.Lipoxygenase pathway receptor expression in ovarian cancer.
P2860
Q21342813-17E20E7B-88DD-4719-A722-493BB6A96570Q24301660-AFCD9AD8-C051-4A23-BDCA-640E35828621Q24685466-DD26EE9F-43B0-41EC-8915-A162A686346CQ24800010-9AA9BF01-7A21-40F9-A5A6-A85E03FA87D5Q28270980-1EC8C6AF-7E65-42B2-BA21-3EFE681BFE91Q28344283-112E619A-9DF9-4DA6-9840-41B447F30891Q28658683-08107AD4-FCB3-4A57-8EAD-7BA091DDD345Q33297978-C78B2D2E-C4F0-46D3-9475-11D05315CD23Q33582732-86F1A2AA-087F-44CD-8E02-F283EFCFBB1FQ33662463-DCCED2EB-F191-4B49-B544-865A2AD76765Q33702052-E090E74C-AD9C-40C5-8ABB-C0F7664B0BF2Q33955652-C36C8A75-E5EB-4CFF-96AC-E67A6D47F02FQ34067846-F3DAF6B3-27D4-456F-82C4-904C33686150Q34153217-7FE4091E-7CB6-429D-8F0B-B6F3EAD3BCF6Q34658888-218F166A-7E40-4573-B086-E5F7EAB038B5Q34874016-190A06E6-F8A4-44A7-B9A9-53F7E3F04AC2Q35066362-85577620-B0A5-43A9-A751-E3FEDC36015AQ35136815-9CB21001-AD2E-4120-8007-449813540798Q36195133-4292679E-52A1-443C-92B5-C04A446DAAB6Q36503568-3B1D1FDE-6BE6-43B6-88AE-A0F76F60489AQ36623872-5351AC75-086E-4D08-A436-95EDBDD08B21Q36675315-64033EDC-89C2-4A6A-959E-58DAF7B4D507Q36830619-858D40FA-8B97-4DFA-84D2-B747644EAF08Q37947960-6ACCB561-AE79-4E6D-A8C2-7CC574E2854CQ38058846-78BB23EC-A6D7-4BDF-A415-0F304BD85052Q38724639-C81AD31B-5174-4E1E-906B-F5C6B115DC74Q38835812-4A9536E6-03AA-4194-9C62-F6FC564AF50BQ39104480-2C79B867-F744-478C-B697-DCB82348BD64Q39555808-4E11D16E-38CF-429B-AA11-2F56B3D36DF8Q39652841-E17EAC69-477F-470E-AD6C-2B34F34A1923Q40086787-1ACF5FE8-D9D2-41C1-AA83-43227E649BF4Q40244603-49824C41-D551-4004-A3A4-05ED43AB9DA6Q40394667-CF6A44CB-A29A-49B6-AB2E-500D9F3D7580Q41812157-747EA06A-0F07-40F4-8565-9595120C21BCQ42997849-3163F2A8-A3AB-4365-9F7F-06BA728B98D5Q43262386-C87D8AC6-0706-40B0-B1CF-8B4AC401E0F3Q43852686-5E0A287E-7B0A-4EF8-8B59-8513B809DC80Q45906573-66411FE0-1592-4983-AD74-18EB6270E057Q46209101-7822BC1B-A2E1-4808-B7FC-F8268BD43D22Q46638059-7BF02F68-23F8-4180-9D74-76938E0C1857
P2860
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@ast
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@en
type
label
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@ast
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@en
prefLabel
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@ast
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@en
P2093
P356
P1476
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
@en
P2093
P304
P356
10.1006/BBRC.1999.1012
P407
P577
1999-07-01T00:00:00Z